Pandemic Prevention and One Health
This infographic video, created as part of a research project undertaken by Dr Katie Woolaston, explains the links between biodiversity and pandemics, and the ‘One Health’ approach used to help minimise pandemic risk:
ACHLR QUT Symposium (10 December 2021) – The TRIPS Waiver: Intellectual Property, Access to Essential Medicines, and the Coronavirus
Session 1 — Pandemics and Public Health Emergencies
- Bill Bowtell, ‘Unmasked: The Politics of Pandemics’
- Associate Professor Wendy Bonython, ‘Themes and Motifs from a Pandemic: The Independent Panel on Pandemic Preparedness’
- Professor Sara Davies, ‘The Two Track Approach to Revise the International Health Regulations and the Proposed Pandemic Treaty (or Can We Have Our Cake and Eat it Too?)’
Session 2 — COVID-19, Patent Law, and the Trips Waiver
- Dr Muhammad Zaheer Abbas, ‘The Proposal of India and South Africa for a TRIPS Waiver’
- Professor Matthew Rimmer, ‘A TRIPS Waiver for Vaccines? President Joe Biden, Intellectual Property, Access to Essential Medicines, and the Coronavirus COVID-19’
- Associate Professor Felicity Deane, ‘Climate Change Technology and the WTO: Will a TRIPS Waiver Support Technology Transfer?’
Session 3 — Comparative Debates about the TRIPS Waiver
- Associate Professor Aisling McMahon, ‘The EU Counter-Proposal to the TRIPS Waiver: Opposition, False Promises and Delaying Real Solutions’
- Dr Jennifer Nguyen and Declan Sakuls (UAEM North America), ‘The TRIPS Waiver and Free the Vaccine: Universities Allied for Essential Medicines’
- Edward Miller, ‘The New Zealand Debate about the TRIPS Waiver’
Session 4 — COVID-19, Consumer Protection, Misinformation, and Fraud
- Samuel Roach, ‘Vaccine Hesitancy and COVID-19 Misinformation’
- Associate Professor Bruce Baer Arnold, ‘COVID Snails in Policy Bottles: Trust, Regulation and Therapeutics’
- Associate Professor Cassandra Cross, ‘Fraud and COVID-19’
Session 5 — COVID-19, Trade Secrets, and Data Protection
- Professor Charles Lawson, ‘TRIPS and the Evil Empire: What would Darth Vader Say?’
- Teddy Henriksen, ‘The Proposal of a Waiver of TRIPS Agreement Section 7: Protection of Undisclosed Information — In Response to Covid-19’
- Dr Michelle Rourke, ‘A Tale of Two Coronaviruses — Data Sharing During Infectious Disease Emergencies’
Conclusion
- Professor Natalie Stoianoff, ‘Beyond the TRIPS Waiver’
- Professor Richard Gold, ‘The Fall of the Innovation Empire and its Possible Rise through Open Science’
Digital Product
- Matthew Rimmer and Muhammad Zaheer Abbas, “Intellectual Property and Access to Essential Medicines: Public Health and the Coronavirus COVID-19” (2020) Coffee with a Colleague (Episode 4)
- Eliana Close and James Downar, “Non-beneficial treatment at the end of life and decision making during the COVID-19 pandemic” (2020) Coffee with a Colleague (Episode 1)
- Muhammad Zaheer Abbas, “Harnessing the Potential of 3D Printing to Develop Emergency Equipment in Response to COVID-19” Intellectual Property and Education in the Age of COVID-19 (2020) Faculty of Law, Queensland University of Technology, Brisbane, Australia
The Conversation and other online sources
- Matthew Rimmer, “Australia stalls vaccine supply” (2021), The Saturday Paper (subscription required)
- Muhammad Zaheer Abbas, “Get jabbed, get cash? Perspectives on introducing a cash incentive for Coronavirus vaccinations” (2021) BEST Talks
- Bill Madden and Tina Cockburn, “How will compo for vax reactions actually work?” (2021) SmartPractice
- Bill Madden and Tina Cockburn, “What’s the new COVID vaccine indemnity scheme?” (2021) The Conversation
- Claire Horwell and Fiona McDonald, “Why you need to wear a facemask in France but not in the UK” (2020) The Conversation UK
- Peta Stephenson and Jonathan Crowe, “Queensland Public Health Laws and COVID-19: A Challenge to the Rule of Law?” (2020) AUSPUBLAW
- Donna Cooper, “Co-parenting in the time of coronavirus: if you and your ex don’t agree what are your legal rights?” (2020) The Conversation
- Donna Cooper, “Mediating with technology: the new normal?” (2020) Queensland Law Society
Invited industry seminars, keynotes, public lectures
- Eliana Close, “Legal Considerations in COVID-19 Triage” (1 October 2020) Palliative Care Australia, Australian COVID-19 Palliative Care Working Group
- Muhammad Zaheer Abbas, “The COVID-19 Pandemic and the Issue of Affordable Access to Innovative Health Technologies: An Analysis of Compulsory Licensing of Patents as a Policy Option” Law and Economics of the 2020 Coronavirus Crisis, University of Notre Dame and University of Lucerne, Switzerland
- Muhammad Zaheer Abbas, “Why Costa Rica’s Proposal for the Creation of a Global Pooling Mechanism Deserves Serious Consideration” (2020) Global Congress Week of Intellectual Property, the Public Interest and Covid-19, Fundación Karisma, Bogotá, Colombia
- B.A.R.R. Ariyaratna, A.A.C.J. Adhikari, W.A. Sanath Sameera Wijesinghe, “The Interplay between Public Interest and Individual Rights during the COVID-19 Outbreak in Sri Lanka: A Comparative Legal Analysys with Selected Jurisdictions” (2020) Conference Paper, Annual Academic Sessions of the Open University of Sri Lanka
- A.A.C.J Adhikari, W.A. Sanath Sameera Wijesinghe, “Making Intellectual Property a Common Good to Combat Global Pandemics: The COVID-19 Technology Access Pool (C-TAP) and the Role of Big Pharma” (2020) 17th International Conference on Business Management
Conferences, public events
- Adjunct Professor Thaddeus Pope, “Patient Rights and Healthcare Decision-Making after COVID-19: Transformations and Future Directions?” QUT Global Law, Science and Technology Seminar Series
Submissions
- Muhammad Zaheer Abbas, “Vaccine related fraud and security risks” (August 2021) Submission to the Australian Parliament’s Joint Committee on Law Enforcement Inquiry into Vaccine Related Fraud and Security Risks
- Muhammad Zaheer Abbas, “Vulnerable Supply Chains in a Health Emergency: Australia, Local Manufacturing and 3D Printing” (April 2021) Submission to the Productivity Commission Inquiry into Vulnerable Supply Chains